HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Eric Gershwin Selected Research

Autoimmune Diseases (Autoimmune Disease)

11/2021The myristoylated alanine-rich C-kinase substrates (MARCKS): A membrane-anchored mediator of the cell function.
5/2021Antibody glycosylation in autoimmune diseases.
1/2021Transcriptome landscape of double negative T cells by single-cell RNA sequencing.
1/2021Enoxacin Up-Regulates MicroRNA Biogenesis and Down-Regulates Cytotoxic CD8 T-Cell Function in Autoimmune Cholangitis.
1/2021Complex regional pain syndrome - Autoimmune or functional neurologic syndrome.
10/2020Clinical Management of Primary Biliary Cholangitis-Strategies and Evolving Trends.
1/2020Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus.
12/2019The Myth of Mycotoxins and Mold Injury.
11/2019Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases.
3/2019Complex regional pain syndrome - False hopes and miscommunications.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Eric Gershwin Research Topics

Disease

192Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2022 - 01/2002
79Autoimmune Diseases (Autoimmune Disease)
11/2021 - 01/2002
52Inflammation (Inflammations)
11/2021 - 08/2002
37Liver Diseases (Liver Disease)
04/2020 - 03/2002
36Cholangitis
01/2021 - 06/2002
31Infections
01/2020 - 10/2002
28Fibrosis (Cirrhosis)
04/2022 - 06/2005
20Neoplasms (Cancer)
10/2021 - 03/2004
18Liver Cirrhosis (Hepatic Cirrhosis)
04/2022 - 05/2003
18Autoimmune Hepatitis
04/2022 - 03/2002
13Sclerosing Cholangitis
01/2022 - 11/2002
13Disease Progression
10/2020 - 06/2002
11Rheumatoid Arthritis
11/2021 - 06/2002
10Cholestasis
01/2021 - 10/2003
10Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2020 - 06/2003
9Hepatitis
04/2022 - 05/2003
9Colitis
01/2018 - 01/2009
8Genetic Predisposition to Disease (Genetic Predisposition)
01/2019 - 05/2003
8Hypersensitivity (Allergy)
02/2016 - 10/2004
7Chronic Hepatitis C
12/2021 - 11/2003
7Virus Diseases (Viral Diseases)
12/2021 - 11/2003
7Anaphylaxis (Anaphylactic Shock)
12/2019 - 10/2004
7Asthma (Bronchial Asthma)
12/2013 - 09/2002
6Non-alcoholic Fatty Liver Disease
01/2018 - 02/2008
6Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2013 - 06/2002
5Rheumatic Diseases (Rheumatism)
01/2020 - 02/2008
5Disease Susceptibility (Diathesis)
06/2018 - 09/2002
5Obesity
03/2014 - 02/2008
5Multiple Sclerosis
10/2013 - 08/2006
4Vasculitis (Vasculitides)
01/2021 - 09/2008
4Connective Tissue Diseases (Connective Tissue Disease)
01/2021 - 10/2008
4Osteonecrosis (Kienbock's Disease)
01/2020 - 10/2002
4Pain (Aches)
03/2019 - 02/2007
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2014 - 06/2008
4Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2013 - 03/2010
4Systemic Scleroderma (Systemic Sclerosis)
12/2012 - 09/2003
3End Stage Liver Disease
01/2022 - 08/2009
3Hepatocellular Carcinoma (Hepatoma)
12/2021 - 10/2015
3Arthritis (Polyarthritis)
01/2021 - 04/2014
3Guillain-Barre Syndrome
01/2021 - 11/2016
3Pruritus (Itching)
10/2020 - 08/2005
3Lupus Nephritis
01/2020 - 12/2012

Drug/Important Bio-Agent (IBA)

76AntibodiesIBA
01/2021 - 02/2002
68AutoantibodiesIBA
04/2022 - 01/2002
45CytokinesIBA
11/2021 - 03/2002
37AutoantigensIBA
06/2018 - 01/2002
28AntigensIBA
10/2020 - 06/2002
25XenobioticsIBA
01/2018 - 02/2002
21Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2002
16Immunoglobulin M (IgM)IBA
06/2018 - 01/2003
15Biomarkers (Surrogate Marker)IBA
12/2021 - 05/2006
14Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020 - 10/2002
13Immunoglobulin G (IgG)IBA
04/2022 - 01/2003
13Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA
01/2022 - 06/2002
13ChemokinesIBA
01/2021 - 09/2005
13Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2021 - 05/2007
12Immunoglobulins (Immunoglobulin)IBA
05/2021 - 02/2005
12Biological ProductsIBA
01/2021 - 01/2002
12Pharmaceutical PreparationsIBA
01/2018 - 09/2004
11EpitopesIBA
01/2022 - 01/2002
11Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
01/2018 - 08/2006
11Oxidoreductases (Dehydrogenase)IBA
09/2013 - 06/2002
10Bile Acids and Salts (Bile Acids)IBA
01/2022 - 01/2016
10InterleukinsIBA
01/2018 - 11/2009
10Pyruvic Acid (Pyruvate)IBA
09/2013 - 06/2002
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2021 - 08/2006
9LigandsIBA
01/2021 - 09/2005
7EnzymesIBA
01/2022 - 11/2004
7VaccinesIBA
11/2020 - 01/2002
7SteroidsIBA
01/2020 - 10/2002
72-octynoic acidIBA
12/2018 - 05/2005
7InterferonsIBA
01/2018 - 05/2006
7Interleukin-17 (Interleukin 17)IBA
12/2016 - 02/2009
7Interleukin-12 (IL 12)IBA
12/2015 - 03/2012
6Interleukin-6 (Interleukin 6)IBA
01/2021 - 03/2009
6Interferon-gamma (Interferon, gamma)IBA
12/2020 - 06/2008
6Immunoglobulin A (IgA)IBA
12/2019 - 05/2004
6Immunoglobulin E (IgE)IBA
12/2019 - 08/2005
5MicroRNAs (MicroRNA)IBA
11/2021 - 05/2009
5Immunosuppressive Agents (Immunosuppressants)IBA
04/2020 - 06/2011
5Anti-Bacterial Agents (Antibiotics)IBA
12/2019 - 04/2008
5CollagenIBA
07/2019 - 10/2008
5Therapeutic UsesIBA
01/2018 - 07/2010
5Sodium Glutamate (Accent)IBA
03/2014 - 02/2008
4Peptides (Polypeptides)IBA
01/2022 - 08/2006
4CD40 Ligand (CD40L)IBA
01/2018 - 06/2005
4Interleukin-4 (Interleukin 4)IBA
01/2018 - 02/2014
4Monoclonal AntibodiesIBA
01/2017 - 03/2009
4Toll-Like Receptors (Toll-Like Receptor)IBA
10/2015 - 08/2006
4Interleukin-2 Receptors (IL 2 Receptor)IBA
11/2010 - 08/2006
3ImmunosorbentsIBA
01/2022 - 06/2005
3Glycoproteins (Glycoprotein)IBA
01/2022 - 01/2019
3Transforming Growth Factors (Transforming Growth Factor)IBA
12/2021 - 09/2007

Therapy/Procedure

39Therapeutics
01/2021 - 05/2006
10Liver Transplantation
01/2022 - 05/2007
8Immunotherapy
01/2018 - 08/2002
4Transplantation
01/2019 - 03/2007
4Bone Marrow Transplantation (Transplantation, Bone Marrow)
12/2010 - 01/2006
3Drug Therapy (Chemotherapy)
01/2021 - 02/2010
3Biological Therapy
01/2021 - 02/2010